Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: Reappraisal with a meta-analysis of randomized controlled trials

Journal of Clinical Oncology

Volumn 22, Issue 19, 2004, Pages 3860-3867

  Hotta, Katsuyuki ^a   Matsuo, Keitaro ^a   Ueoka, Hiroshi ^a   Kiura, Katsuyuki ^a   Tabata, Masahiro ^a   Tanimoto, Mitsune ^a  

^a OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; GEMCITABINE; NAVELBINE; PACLITAXEL; PLATINUM;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HAZARD ASSESSMENT; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; META ANALYSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; ADJUVANT CHEMOTHERAPY; LUNG TUMOR; MULTIMODALITY CANCER THERAPY; REPRODUCIBILITY; SURVIVAL RATE; TREATMENT OUTCOME;

CARCINOMA, NON-SMALL-CELL LUNG; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; HUMANS; LUNG NEOPLASMS; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 5444235033     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2004.01.153     Document Type: Article

References (27)

1. Stanley K, Stjernswa RD J: Lung cancer: A worldwide health problem. Chest 96:1-5, 1989
2. Ferlay J, Bray F. Pisani P, et al: GLOBOCAN 2000: Cancer Incidence, Mortality and Prevalence Worldwide. Version 1.0. IARC CancerBase No. 5, Lyon, France, IARC Press, 2001
3. Mountain CF: Revisions in the international system for staging lung cancer. Chest 111:1710-1717, 1997
4. Non-small Cell Lung Cancer Collaborative Group Chemotherapy in non-small cell lung cancer: A meta-analysis using updated data on individual patients from 52 randomized clinical trials. BMJ 311:899-909, 1995
5. Xu G, Rong T, Lin P: Adjuvant chemotherapy following radical surgery for non-small cell lung cancer: A randomized study on 70 patients. Chin Med J 113:617-620, 2000
6. Tanaka F, Wada H: Postoperative oral administration of UFT for completely resected pathological stage I non-small cell lung cancer: The West Japan study group for lung cancer surgery (WJSG), the 4th study. Eur J Cancer 37:29, 2001 (abstr 96)
7. Mineo TC, Ambrogi V, Corsaro V, et al: Postoperative adjuvant therapy for stage IB non-small cell lung cancer. Eur J Cardiothorac Surg 20:378-384, 2001
8. Tada H, Tsuchiya R, Ichinose Y, et al: A randomized trial comparing adjuvant chemotherapy versus surgery alone for completely resected pN2 non-small cell lung cancer (JCOG9304). Lung Cancer 43:167-173, 2004
9. Tada H, Yasumitsu T, Iuchi K, et al: Randomized study of adjuvant chemotherapy for completely resected non-small cell lung cancer: Lack of prognostic significance in DNA ploidy pattern at adjuvant setting. Proc Am Soc Clin Oncol 21:313, 2002 (abstr 1250)
10. Scagliotti GV, Fossati R, Torri V, et al: Randomized study of adjuvant chemotherapy for completely resected stage I, II, or IIIA non-small cell lung cancer. J Natl Cancer Inst 95:1453-1461, 2003
11. Arriagada R, Bergman B, Dunant A, et al: Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. N Engl J Med 350:351-360, 2004
12. Waller D, Fairlamb DJ, Gower N, et al: The Big Lung Trial (BLT): Determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC)-Preliminary results in the surgical setting. Proc Am Soc Clin Oncol 22:632, 2003 (abstr 2543).
13. Imaizumi M: A randomized trial of postoperative adjuvant chemotherapy for p-stage I non small cell lung cancer: Proc World Conference on Lung Cancer 41:54, 2003 (abstr O-180).
14. Endo C, Saito Y, Iwanami H, et al: A randomized trial of postoperative UFT therapy in p stage I, II non-small cell lung cancer: North-east Japan Study Group for Lung Cancer Surgery. Lung Cancer 40:181-186, 2003
15. Kato H, Ichinose Y, Ohta M, et al: A randomized trial of adjuvant chemotherapy with Uracil-Tegafur for adenocarcinoma of the lung. N Engl J Med 350:1713-1721, 2004
16. Jadad AR, Moore RA, Carroll D, et al: Assessing the quality of reports of randomized clinical trials: Is blinding necessary? Control Clin Trials 17:1-12, 1996
17. Parmar MB, Torri V, Stewart L: Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. Stat Med 17:2815-2834, 1998
18. DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials 7:177-188, 1986
19. Begg CB, Mazumdar M: Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101, 1994
20. Egger M, Smith GD, Schneider M, et al: Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-634, 1997
21. Thompson SG, Sharp SJ: Explaining heterogeneity in meta-analysis: A comparison of methods. Stat Med 18:2693-2708, 1999
22. Keicho N, Saijo N, Shinkai T, et al: Phase II study of UFT in patients with advanced non-small cell lung cancer. Jpn J Clin Oncol 16:143-146, 1986
23. Tanaka F, Wada H, Fukushima M: Antiangiogenic effect of UFT and its clinical significance in postoperative adjuvant therapy for NSCLC. Proc Am Soc Clin Oncol 21:213b, 2002 (abstr 2669).
24. Wada H, Miyahara R, Tanaka F, et al: Postoperative adjuvant chemotherapy with PVM (cisplatin+vindesine + mitomycin C) and UFT (uracil+tegaful) in resected stage I-II NSCLC(non-small cell lung cacner): A randomized clinical trial. Euro J Cardiothorac Surg 15:438-443, 1999
25. Clarke MJ, Stewart LA: Obtaining individual patient data from randomized controlled trials, in Egger M, Smith GD, Altman DG (eds): Systematic Reviews in Health Care. London, UK, BMJ Publishing Group, 2001, pp 109-121
26. Depierre A, Milleron B, Moro-Sibilot D, et al: Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. J Clin Oncol 20:247-253, 2002
27. Rosell R, Felip E, Maestre J, et al: The role of chemotherapy in early non-small-cell lung cancer management. Lung Cancer 34:63-74, 2001 (suppl 3)